SSc May Be Linked to Subtle Cognitive Changes

• by Andrea Surnit

• April 30, 2026

FDA Approves Atacicept for IgA Nephropathy

The approval was based on reduced proteinuria, and an ongoing trial is required to determine whether atacicept slows long-term kidney function decline.

• by Kathryn Wighton

• July 7, 2026

• 3 min

Sjögren Disease—B Cells at the Brink: From Autoimmunity to Lymphomagenesis and the Rise of Novel B Cell–Targeted Therapies

• by Rachael A. Gordon, Sara S. McCoy

• July 1, 2026

FDA approves oral dermatomyositis therapy

Phase 3 findings show improvements in physical function and skin disease activity.

• by Kathryn Wighton

• August 28, 2026

• 2 min